- Hem
- Om universitetet
- Hitta person
- Per Albertsson
Per Albertsson
Anknuten till forskning
Avd för onkologiOm Per Albertsson
Onkolog med inriktning på strålbehandling. Forskar mest på intern strålbehandling med alfastrålanderadionuklider. I huvudsak studeras astat-211 (211At). Studierna rör pre-klinik till tidiga fas-I studier.
Forskning stöds av
Cancer Fonden, Jubileumklinikens Cancer Fond (JKCF), Vetenskapsrådet, ALF.
-
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal
cancer
M. P. Nilsson, C. Undseth, Per Albertsson, M. Eidem, B. M. Havelund, J. Johannsson, A. Johnsson, C. Radu, E. Serup-Hansen, K. L. Spindler, B. Zakrisson, M. G. Guren, C. Kronborg
Acta Oncologica - 2023 -
Astatine-211 based radionuclide therapy: Current clinical trial
landscape
Per Albertsson, Tom Bäck, Karin Bergmark, Andreas Hallqvist, Mia Johansson, Emma Aneheim, Sture Lindegren, Chiara Timperanza, K. Smerud, Stig Palm
Frontiers in Medicine - 2023 -
Societal costs of ovarian cancer in a population-based cohort - a cost of illness
analysis
Charlotte Palmqvist, Josefine Persson, Per Albertsson, Pernilla Dahm-Kähler, Mia Johansson
Acta Oncologica - 2022 -
Complications after advanced ovarian cancer surgery-A population-based cohort
study
Charlotte Palmqvist, H. Michaelsson, C. Staf, Mia Johansson, Per Albertsson, Pernilla Dahm-Kähler
Acta Obstetricia Et Gynecologica Scandinavica - 2022 -
Estimating the risk for secondary cancer following targeted alpha therapy with astatine-211 intraperitoneal
radioimmunotherapy.
Erik Leidermark, Andreas Hallqvist, Lars Jacobsson, Per Karlsson, Erik Holmberg, Tom Bäck, Mia Johansson, Sture Lindegren, Stig Palm, Per Albertsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2022 -
Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian
cancer
Stig Palm, Tom Bäck, Emma Aneheim, Andreas Hallqvist, Ragnar Hultborn, Lars Jacobsson, H. Jensen, Sture Lindegren, Per Albertsson
Translational Oncology - 2021 -
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow
up.
Chaido Chamalidou, H Fohlin, Per Albertsson, L-G Arnesson, Zakaria Einbeigi, Erik Holmberg, A Nordenskjöld, B Nordenskjöld, Per Karlsson, Barbro Linderholm
Breast (Edinburgh, Scotland) - 2021 -
Increased disease-free and relative survival in advanced ovarian cancer after centralized primary
treatment
Charlotte Palmqvist, C. Staf, Constantina Mateoiu, Mia Johansson, Per Albertsson, Pernilla Dahm-Kähler
Gynecologic Oncology - 2020 -
Realizing Clinical Trials with Astatine-211: The Chemistry
Infrastructure
Sture Lindegren, Per Albertsson, Tom Bäck, H. Jensen, Stig Palm, Emma Aneheim
Cancer Biotherapy and Radiopharmaceuticals - 2020 -
Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone
microtumors
Tom Bäck, Karin Jennbacken, Malin Hagberg Thulin, Sture Lindegren, H. Jensen, T. Olafsen, P. J. Yazaki, Stig Palm, Per Albertsson, Jan-Erik Damber, A. M. Wu, Karin Welén
Ejnmmi Research - 2020 -
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo
Behavior
Y. Dekempeneer, Tom Bäck, Emma Aneheim, H. Jensen, J. Puttemans, C. Xavier, M. Keyaerts, Stig Palm, Per Albertsson, T. Lahoutte, V. Caveliers, Sture Lindegren, M. D'Huyvetter
Molecular Pharmaceutics - 2019 -
Radiosensitivity: Gender and Order of Administration of G-CSF, An Experimental Study in
Mice
Ragnar Hultborn, Per Albertsson, Susanne Ottosson, Elisabet Warnhammar, Åsa Palm, Stig Palm, Kerstin Elmroth
Radiation Research - 2019 -
Towards elucidating the radiochemistry of astatine - Behavior in
chloroform
Emma Aneheim, Stig Palm, H. Jensen, C. Ekberg, Per Albertsson, Sture Lindegren
Scientific Reports - 2019 -
Breast cancer survival trends in different stages and age groups - a population-based study
1989-2013.
Anna Nordenskjöld, Helena Fohlin, Lars G Arnesson, Zakaria Einbeigi, Erik Holmberg, Per Albertsson, Per Karlsson
Acta oncologica (Stockholm, Sweden) - 2019 -
Intraperitoneal alpha-Emitting Radioimmunotherapy with At-211 in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose
Estimations
Andreas Hallqvist, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, H. Jensen, Lars Jacobsson, Ragnar Hultborn, Stig Palm, Per Albertsson
Journal of Nuclear Medicine - 2019 -
Astatine-211: The Chemistry
Infrastructure.
Sture Lindegren, Tom Bäck, Stig Palm, Holger Jensen, Per Albertsson, Emma Aneheim
Journal of Medical Imaging and Radiation Sciences - 2019 -
Intraperitoneal Alpha-emitting Radio Immunotherapy with Astatine-211 in Relapsed Ovarian Cancer; Long-term Follow-up with Individual Absorbed Dose
Estimations.
Andreas Hallqvist, Per Albertsson, Ragnar Hultborn, Stig Palm, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, Holger Jensen, Lars Jacobsson
Journal of Medical Imaging and Radiation Sciences - 2019 -
Estimation of Long-term Risks for Cancer Induction following Adjuvant Targeted Alpha Therapy with Curative
Intent.
Stig Palm, Andreas Hallqvist, Emma Aneheim, Tom Bäck, Mia Johansson, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Per Albertsson
Journal of Medical Imaging and Radiation Sciences - 2019 -
Quantified Cell Binding of Astatinated Immunoconjugates onOvarian Cancer Cell Spheroids by Alpha Camera
Imaging.
Tom Bäck, M Verhoeven, Emma Aneheim, Per Albertsson, Stig Palm, Sture Lindegren, Holger Jensen
Journal of Medical Imaging and Radiation Sciences - 2019 -
Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor
Sizes.
Stig Palm, Tom Bäck, Sture Lindegren, Ragnar Hultborn, Lars Jacobsson, Per Albertsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2018 -
MR and CT data with multiobserver delineations of organs in the pelvic areaPart of the Gold Atlas
project
T. Nyholm, S. Svensson, S. Andersson, J. Jonsson, Maja Sohlin, C. Gustafsson, E. Kjellen, K. Soderstrom, Per Albertsson, L. Blomqvist, B. Zackrisson, L. E. Olsson, A. Gunnlaugsson
Med Phys - 2018 -
Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and
meta-analysis
Per Albertsson, Charlotte Alverbratt, Ann Liljegren, Emil Björkander, Annika Strandell, Ola Samuelsson, Stig Palm, Andreas Hallqvist
Critical reviews in oncology/hematology - 2018 -
Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen,
NaPi2b
Kristina Levan, Martin Mehryar, Constantina Mateoiu, Per Albertsson, Tom Bäck, Karin Sundfeldt
Bmc Cancer - 2017 -
Positron emission tomography and computed tomographic imaging (PET/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: A systematic review and
meta-analysis.
Andreas Hallqvist, Charlotte Alverbratt, Annika Strandell, Ola Samuelsson, Emil Björkander, Ann Liljegren, Per Albertsson
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 2017 -
Accelerated or conventional whole brain irradiation of malignant
melanoma.
Ragnar Hultborn, Johanna Sand, Sara Kinhult, Lotta Lundgren, Ulrika Stierner, Ingela Turesson, Per Albertsson
Acta oncologica (Stockholm, Sweden) - 2017 -
Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated alpha-Radioimmunotherapy with At-211-MX35-F(ab')(2): Influence of Absorbed Tumor Dose and Effect on Long-Term
Survival
Tom Bäck, N. Chouin, Sture Lindegren, Helena Kahu, H. Jensen, Per Albertsson, Stig Palm
Journal of Nuclear Medicine - 2017 -
Therapeutic efficacy of alpha-radioimmunotherapy with different activity levels of the Bi-213-labeled monoclonal antibody MX35 in an ovarian cancer
model
Anna Gustafsson-Lutz, Tom Bäck, Emma Aneheim, Ragnar Hultborn, Stig Palm, Lars Jacobsson, A. Morgenstern, F. Bruchertseifer, Per Albertsson, Sture Lindegren
EJNMMI Research - 2017 -
Biokinetic modeling and dosimetry for optimizing intraperitoneal radioimmunotherapy of ovarian cancer
microtumors.
Stig Palm, Tom Bäck, Börje Haraldsson, Lars Jacobsson, Sture Lindegren, Per Albertsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2016 -
Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide
Immunoconjugates
Emma Aneheim, Anna Gustafsson, Per Albertsson, Tom Bäck, Holger Jensen, Stig Palm, Sofia Svedhem, Sture Lindegren
Bioconjugate chemistry - 2016 -
No clear effect of postoperative radiotherapy on survival of breast cancer patients with 1-3 positive nodes: A population-based
study.
Anna Nordenskjöld, H I Fohlin, Per Albertsson, L G Arnesson, C Chamalidou, Zakaria Einbeigi, Erik Holmberg, B Nordenskjöld, Per Karlsson
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO - 2015 -
Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer
Patients.
Elin Cederkrantz, Håkan Andersson, Peter Bernhardt, Thomas Backhaus, Ragnar Hultborn, Lars Jacobsson, Holger Jensen, Sture Lindegren, Michael Ljungberg, Tobias Magnander, Stig Palm, Per Albertsson
International journal of radiation oncology, biology, physics - 2015 -
Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version
Rebmab200.
Sture Lindegren, Luciana N S Andrade, Tom Bäck, Camila Maria L Machado, Bruno Brasil Horta, Carlos Buchpiguel, Ana Maria Moro, Oswaldo Keith Okamoto, Lars Jacobsson, Elin Cederkrantz, Kohshin Washiyama, Emma Aneheim, Stig Palm, Holger Jensen, Maria Carolina B Tuma, Roger Chammas, Ragnar Hultborn, Per Albertsson
PloS one - 2015 -
Automated astatination of biomolecules--a stepping stone towards multicenter clinical
trials.
Emma Aneheim, Per Albertsson, Tom Bäck, Holger Jensen, Stig Palm, Sture Lindegren
Scientific reports - 2015 -
Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported
outcomes.
Bo Lennernäs, Khairul Majumder, Jan-Erik Damber, Per Albertsson, Erik Holmberg, Yvonne Brandberg, Ulf Isacsson, Gunilla Ljung, Ole Damm, Sten Nilsson
Acta oncologica (Stockholm, Sweden) - 2015 -
Shelf-Life of e-Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugates, Precursors for At-211 Labeling of
Antibodies
Emma Aneheim, Jenny Halleröd, Per Albertsson, H. Jensen, Stellan Holgersson, Sture Lindegren
Cancer Biotherapy and Radiopharmaceuticals - 2015 -
Astatine-211 labeling: a study towards automatic production of astatinated
antibodies
Emma Aneheim, Holger Jensen, Per Albertsson, Sture Lindegren
Journal of Radioanalytical and Nuclear Chemistry - 2015 -
Modelling the biokinetics of intra-peritoneally administered targeted alpha therapy on patients for improved
dosimetry.
Stig Palm, Tom Bäck, Sture Lindegren, Holger Jensen, Per Albertsson, Lars Jacobsson
Journal of Nuclear Medicine - 2014 -
Effective dose of intraperitoneal α-radioimmunotherapy with
211At.
Elin Cederkrantz, Tom Bäck, Lars Jacobsson, Holger Jensen, Sture Lindegren, Stig Palm, Per Albertsson
Journal of Nuclear Medicine - 2014 -
Image-based small-scale 3D-dosimetry in targeted alpha therapy using voxel dose-point kernels and alpha camera imaging of serial tissue
sections.
Tom Bäck, Nicolas Chouin, Sture Lindegren, Holger Jensen, Per Albertsson, Stig Palm
Journal of Nuclear Medicine - 2014 -
Polylysine-based Effector Molecules and Clearing Agents for Pretargeting Systems in Therapy and Imaging – Increasing Avidity and Specific Activity and Providing Many Ways to Optimize In Vivo
Distribution.
Anna Gustafsson-Lutz, Tom Bäck, Per Albertsson, Stig Palm, A Morgenstern, F Bruchertseifer, Sture Lindegren
European Journal of Nuclear Medicine and Molecular Imaging - 2014 -
Intra-tumoral dose distributions after experimental targeted alpha therapy by Alpha-Camera
imaging.
Nicolas Chouin, Stig Palm, Sture Lindegren, Holger Jensen, Per Albertsson, Tom Bäck
European Journal of Nuclear Medicine and Molecular Imaging - 2014 -
Predictors of long-term outcome of percutaneous coronary intervention in octogenarians with acute coronary
syndrome
Salim B. Barywani, Maria Lindh, Josefin Ekelund, Max Petzold, Per Albertsson, Maria Schaufelberger, L. Lund, Michael Fu
IJC Heart and Vessels - 2014 -
The Potential and Hurdles of Targeted Alpha Therapy - Clinical Trials and
Beyond.
Jörgen Elgqvist, Sofia Frost, Jean-Pierre Pouget, Per Albertsson
Frontiers in oncology - 2014 -
Ex Vivo Activity Quantification in Micrometastases at the Cellular Scale Using the α-Camera
Technique.
Nicolas Chouin, Sture Lindegren, Sofia Frost, Holger Jensen, Per Albertsson, Ragnar Hultborn, Stig Palm, Lars Jacobsson, Tom Bäck
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2013 -
Comparison of (211)At-PRIT and (211)At-RIT of Ovarian Microtumors in a Nude Mouse
Model.
Sofia Frost, Tom Bäck, Nicolas Chouin, Ragnar Hultborn, Lars Jacobsson, Jörgen Elgqvist, Holger Jensen, Per Albertsson, Sture Lindegren
Cancer biotherapy & radiopharmaceuticals - 2013 -
Tumor Growth of Subcutaneous Xenografts after Repeated Alpha-Radioimmunotherapy with Astatine-211: What Absorbed Dose is Required to Treat Solid Tumors with Alpha-particle
Emitters?
Tom Bäck, Nicolas Chouin, Sture Lindegren, Holger Jensen, Stig Palm, Per Albertsson
European Journal of Nuclear Medicine and Molecular Imaging - 2012 -
Quantification of activity by alpha-camera imaging and small-scale dosimetry within ovarian carcinoma micrometastases treated with targeted alpha
therapy.
Nicolas Chouin, Sture Lindegren, Holger Jensen, Per Albertsson, Tom Bäck
Quarterly Journal of Nuclear Medicine and Molecular Imaging - 2012 -
Intraperitoneal Radionuclide Therapy:Clinical and Pre-Clinical
Considerations.
Jörgen Elgqvist, Sture Lindegren, Per Albertsson
Ovarian Cancer- Clinical and Therapeutuc Perspectives. - 2012 -
Comparison of therapeutic efficacy and biodistribution of (213)Bi- and (211)At-labeled monoclonal antibody MX35 in an ovarian cancer
model.
Anna Gustafsson, Tom Bäck, Jörgen Elgqvist, Lars Jacobsson, Ragnar Hultborn, Per Albertsson, Alfred Morgenstern, Frank Bruchertseifer, Holger Jensen, Sture Lindegren
Nuclear medicine and biology - 2012 -
A Phase I Study of Concurrent Chemoradiotherapy and Cetuximab for Locally Advanced Esophageal
Cancer
Cecilie Holländer, Lene Baeksgaard, Morten Sorensen, Per Albertsson, Lars Damstrup, Ulrik Lassen
Anticancer research - 2012 -
Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated
angiogenesis.
Per Albertsson, Bo Lennernäs, Klas Norrby
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica - 2012 -
Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate
cancer.
Åsa Jellvert, Ingela Franck-Lissbrant, Maliha Edgren, Elisabeth Ovferholm, Karin Braide, Ann-Marie Ekelund Olvenmark, Jon Kindblom, Per Albertsson, Bo Lennernäs
Experimental and therapeutic medicine - 2011 -
Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and
immunomodulation.
Karin Edsparr, Per H Basse, Ronald H Goldfarb, Per Albertsson
Cancer microenvironment : official journal of the International Cancer Microenvironment Society - 2011 -
A pharmacological analysis of the cholinergic regulation of urokinase-type plasminogen activator secretion in the human colon cancer cell line,
HT-29.
Ann Novotny, Karin Edsparr, Gunnar Nylund, Amir Khorram-Manesh, Per Albertsson, Svante Nordgren, Dick Delbro
European journal of pharmacology - 2010 -
Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line
YT.
Karin Edsparr, Frank M Speetjens, Adri Mulder-Stapel, Ronald H Goldfarb, Per H Basse, Bo Lennernäs, Peter J K Kuppen, Per Albertsson
Journal of immunotherapy (Hagerstown, Md. : 1997) - 2010 -
Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated
angiogenesis.
Per Albertsson, Bo Lennernäs, Klas Norrby
Acta oncologica (Stockholm, Sweden) - 2009 -
Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP
expression.
Karin Edsparr, Bengt R Johansson, Ronald H Goldfarb, Per H Basse, Ulf Nannmark, Frank M Speetjens, Peter J K Kuppen, Bo Lennernäs, Per Albertsson
Immunology and cell biology - 2009 -
Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by
VEGF-A.
Per Albertsson, Bo Lennernäs, Klas Norrby
Acta oncologica (Stockholm, Sweden) - 2008 -
Differential locomotion of long- and short-term IL-2-activated murine natural killer cells in a model matrix
environment.
Per Albertsson, P H Basse, Karin Edsparr, M H Kim, R H Goldfarb, R P Kitson, Bo Lennernäs, Ulf Nannmark, Bengt R Johansson
Scandinavian journal of immunology - 2007 -
Delayed start of adjuvant 5-FU/leucovorin based chemotherapy in colon cancer is safe up to 12 weeks
postoperatively
Göran Carlsson, Per Albertsson, Bengt Gustavsson
Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition) - 2007 -
Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate
cancer
Bo Lennernäs, Per Albertsson, M. Edgren, S. Nilsson
Oncol Rep - 2007 -
On metronomic chemotherapy: modulation of angiogenesis mediated by
VEGE-A
Per Albertsson, Bo Lennernäs, Klas Norrby
Acta oncologica (Stockholm, Sweden) - 2006 -
The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by
thrombospondin
Jan-Erik Damber, Christina Vallbo, Per Albertsson, Bo Lennernäs, Klas Norrby
Cancer Chemother Pharmacol - 2006 -
High dose-rate brachytherapy of prostate cancer utilising Iridium-192 after-loading technique: technical and methodological
aspects
M. Edgren, Ann-Marie Ekelund Olvenmark, Per Albertsson, Lena-Marie Lundberg, A. Ullen, S. Levitt, S. Nilsson, Bo Lennernäs
Int J Oncol - 2006 -
Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T
cells.
Q. Yang, S Goding, M Hagenaars, T Carlos, Per Albertsson, P Kuppen, Ulf Nannmark, M E Hokland, P H Basse
Cancer immunology, immunotherapy : CII - 2006 -
Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative
study
Bo Lennernäs, Per Albertsson, Jan-Erik Damber, Klas Norrby
APMIS - 2004 -
The effectiveness of artificial neural networks in evaluating treatment plans for patients requiring external beam
radiotherapy
Bo Lennernäs, D. Sandberg, Per Albertsson, A. Silen, U. Isacsson
Oncol Rep - 2004 -
Chemotherapy and antiangiogenesis--drug-specific, dose-related
effects
Bo Lennernäs, Per Albertsson, H. Lennernas, Klas Norrby
Acta Oncol - 2003 -
Chemotherapy and antiangiogenesis: drug-specific effects on microvessel
sprouting
Per Albertsson, Bo Lennernäs, Klas Norrby
Apmis - 2003 -
The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral
blood.
L. E. Jonges, Per Albertsson, R. L. van Vlierberghe, N. G. Ensink, Bengt R Johansson, C. J. van de Velde, G. J. Fleuren, Ulf Nannmark, P. J. Kuppen
Scandinavian Journal of Immunology - 2001 -
Characterization of Forssman and other antigen/antibody systems in vascularized mouse heart to rat
xenotransplantation.
M. L. Gustavsson, Johnsson C., Per Albertsson, Daniel Jan Lukes, L. M. Steen, Bengt R Johansson, Lars Mjörnstedt, Jonny Norrby, G Tufveson, Michael Olausson
Scandinavian Journal of Immunology - 2001 -
Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer
cells.
Ulf Nannmark, M. E. Hokland, R. Agger, M. Christiansen, J. Kjaergaard, R. H. Goldfarb, Ulf Bagge, M. Unger, Bengt R Johansson, Per Albertsson, P. H. Basse
In Vivo - 2000 -
Matrix metalloproteinases of human NK
cells.
Per Albertsson, M. H. Kim, L. E. Jonges, R. P. Kitson, P. J. Kuppen, Bengt R Johansson, Ulf Nannmark, R. H. Goldfarb
In Vivo - 2000 -
Matrix metalloproteinases in natural killer cells. Expression of MMPs, IL-2 activation and killer cell interactions with Matrigel® and model
tumours
Per Albertsson
2000 -
Infiltration and Lysis of Tumour Cell Aggregates by Adherent lnterleukin-2-Activated Natural Killer Cells Is Distinct from Specific
Cytolysis
Bengt R Johansson, Martin Unger, Per Albertsson, Anna Casselbrant, Ulf Nannmark, Marianne Hokland
Natural immunity - 1996